ProPhase Labs, Inc. PRPH

PRPH Company Overview

ProPhase Labs, Inc. (NASDAQ: PRPH) is a diversified biotechnology, diagnostics, and consumer products company operating across the healthcare, genomics, and direct-to-consumer wellness industries. Historically known for its over-the-counter cold remedy business, the company evolved from a consumer healthcare brand owner into a broader life sciences platform through acquisitions and expansion into diagnostics, genomic sequencing, and oncology-related technologies. Its operations have included diagnostic laboratory services, genomics testing, consumer health products, and contract manufacturing.

The company’s primary revenue drivers have shifted over time depending on market conditions and business mix. During the COVID-19 pandemic, diagnostic testing services became a significant contributor through its laboratory operations. In addition, ProPhase has generated revenue from its consumer health segment, including the longstanding Cold-EEZE brand, as well as from genomics and biotechnology initiatives. The company has positioned itself as a multi-platform healthcare enterprise with exposure to both consumer-facing wellness products and higher-growth precision medicine and diagnostics markets. Public filings and investor disclosures indicate the company has pursued diversification to reduce dependence on any single healthcare vertical.